Glaxo Wins Approval for Bird Flu Vaccine
Made Popular May 19 2008
UK drugs firm GlaxoSmithKline (GSK) has won European Union approval for its vaccine designed to protect people against the H5N1 strain of bird flu.
Add your Comment
Home






